Shareholders that lost money on GSK plc(GSK) should contact Levi & Korsinsky about pending Class Action - GSK
NEW YORK, NY / ACCESS Newswire / March 15, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK
NEW YORK CITY, NY / ACCESS Newswire / March 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds ...
Zacks Investment Research on MSN1d
Why GSK (GSK) is a Top Momentum Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...
Larson Financial Group LLC Has $29,000 Holdings in GSK plc (NYSE:GSK)
Larson Financial Group LLC cut its holdings in GSK plc (NYSE:GSK – Free Report) by 52.7% during the fourth quarter, according ...
Verona Pharma: Great Year For Share Price, But Competition Threatens Bull Thesis
Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.
Fierce Biotech3d
GSK posts data on HIV assets vying for roles in 6-month combo
GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...
GSK falls Tuesday, underperforms market
GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.
GSK shares rise for seven consecutive sessions
Discover GSK's impressive stock surge, boosted by strong earnings, a share buyback program, and a focus on specialty medicines.
Bank of New York Mellon Corp Acquires 20,659 Shares of GSK plc (NYSE:GSK)
Bank of New York Mellon Corp grew its position in GSK plc (NYSE:GSK – Free Report) by 2.2% during the fourth quarter, ...
GSK rallies Friday, outperforms market
GSK PLC closed 15.88% below its 52-week high of £18.24, which the company reached on May 16th.
Zacks Investment Research on MSN8d
Glaxo (GSK) Up 8% Since Last Earnings Report: Can It Continue?
It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...
Share Prices12d
GSK says US FDA accepts two depemokimab indication submissions
(Alliance News) - GSK PLC on Monday said the US Food & Drug Administration has accepted for review the biologics license application for depemokimab in two indications - for asthma with type 2 ...